For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
1
views
0
references
 Top references
cited by
2
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      Effective Downregulation of BCR-ABL Tumorigenicity by RNA Targeted CRISPR-Cas13a.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To induce BCR-ABL gene silencing using CRISPR Cas13a.

          Related collections

          Author and article information

          Journal
          Journal ID (iso-abbrev): Curr Gene Ther
          Title: Current gene therapy
          Publisher: Bentham Science Publishers Ltd.
          ISSN (Electronic): 1875-5631
          ISSN (Print): 1566-5232
          Publication date (Electronic): 2021
          Volume: 21
          Issue: 3
          Affiliations
          [1 ] Pediatric Hematology-Oncology Unit, Department of Pediatrics, Advanced Pediatric Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
          Article
          Publisher Item ID: CGT-EPUB-114311
          DOI: 10.2174/1566523221666210217155233
          PubMed ID: 33596804
          SO-VID: e47b5ac3-f038-4d80-aa05-9d70f83b988f
          History

          Keywords: BCR-ABL,RNA cleavage,hematology,molecular biology,oncology,CRISPR
          Data availability:
          Keywords: BCR-ABL, RNA cleavage, hematology, molecular biology, oncology, CRISPR

          Comments

          Comment on this article